1. Deficiency of tumor-expressed B7-H3 augments anti-tumor efficacy of anti-PD-L1 monotherapy rather than the combined chemoimmunotherapy in ovarian cancer. (December 2022) Authors: Huang, Mingyan; Luo, Jianhua; Ji, Xinpei; Hu, Miao; Xue, Yiquan; Liu, Qiuyan Journal: Pharmacological research Issue: Volume 186(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗